Development of effective cryopreservation protocols will be essential to realizing the potential for clinical application of neural stem and progenitor cells. Current cryopreservation protocols have been largely employed in research, which does not require as stringent consideration of viability and sterility. Therefore, these protocols involve the use of serum and protein additives, which can potentially introduce contaminants, and slow cooling with DMSO/glycerol-based cryopreservation solutions, which impairs cell survival. We investigated whether serum-and protein-free vitrification is effective for functional cryopreservation of neurosphere cultures of neural stem or progenitor cells. To protect the samples from introduction of other contaminants during handling and cryostorage, an original "straw-in-straw" method (250 µl sterile straw placed in 500 µl straw) for direct immersion into liquid nitrogen and storing the samples was also introduced. The protocol employed brief step-wise exposure to vitrification solution composed of ethylene glycol (EG) and sucrose (40% v/v EG, 0.6 M sucrose) and removal of vitrification solution at room temperature. Evaluation of the effects of vitrification revealed that there were no differences between control and vitrified neural stem or progenitor cells in expression of the neural stem or progenitor cell markers, proliferation, or multipotent differentiation. This sterile method for the xeno-free cryopreservation of murine neurospheres without animal or human proteins may have the potential to serve as a starting point for the development of cryopreservation protocols for human neural stem and progenitor cells for clinical use.
INTRODUCTION
dysfunctions in proliferation and neurogenesis (4, 37) . While telomere shortening can be avoided by immortalization with overexpression of human telomerase reverse The potential clinical implications of neural stem and progenitor cell (NSPCs) therapies in the repair of ner-transcriptase (hTERT) (1), long-term culture of human neural progenitor cells immortalized in this manner can vous system injuries and disorders are immense. It is likely that safe and efficient cryopreservation of the result in accumulation of karyotypic abnormalities (36) . Such chromosomal abnormalities can in turn lead to ab-NSPCs will be a prerequisite for quality assurance in the storage and distribution of the cells for clinical use (26) .
normal proliferation and transformation of progenitor or stem cell characteristics, although this is not necessarily Effective storage to ensure reproducible supply of cells would benefit both future clinical applications and cur-an inevitable consequence of all immortalization protocols (8, 21, 27) . This could influence experimental results rent basic research into the functions and properties of NSPCs. While stem cells self-renew, NSPCs cannot be and their interpretation and, on clinical application, may be associated with increased risk of tumorigenesis. De-maintained indefinitely by continuous passaging in culture. For example, when cultured long term, telomere velopment of efficient cryopreservation techniques is therefore essential. shortening in NSPCs leads to senescence and associated It is anticipated that sterile and xeno-free culture and tions containing solute concentrations supporting vitrification (32) . To establish the efficacy of a method for the storage protocols will be a requirement for the ultimate realization of the clinical application of NSPCs. Sterile cryopreservation of stem cells, it is essential to demonstrate that the cells preserve expression of stem cell and reproducible cryostorage protocols would also facilitate basic research. As has been discussed in the fields markers and the capacity for multipotent differentiation. Preservation of the capacity for multipotent differentia-of mesenchymal and embryonic stem cell research [for review see (13, 23, 24) ], the use of animal derivatives and tion is important because any application in replacement therapy would require that stem cells differentiate into other organic components increases the risk of contamination and batch-to-batch variability. In view of the require-functional cell types for integration into neural networks to replace the particular neural cell types that are dam-ment for sterility, we demonstrated that cryopreservation of biological material by vitrification can be achieved us-aged or lost. In the present study, we aim to establish whether our protein-and serum-free vitrification proto-ing only nonbiological additives (17, 19, 22, 32, 38) . We have also developed a protocol using a sealed "straw-in-col has the potential for effective stem cell cryopreservation for clinical and research applications. Using NSPCs straw" configuration (250 µl sterile straw placed in 500 µl straw), which enables maintenance of sterility during we evaluate whether expression of neural stem cells markers, proliferative capacity, and the potential for multipo-cryopreservation (18, 19) . The protocol is both cost-and time-effective as it does not need expensive slow-cool-tent neural differentiation are maintained following vitrification. ing apparatus and requires only direct immersion into liquid nitrogen for cooling.
MATERIALS AND METHODS

Approaches to cryopreservation can be classified as
Culture of NSPCs "freezing" and "vitrification." Cryoprotectants are used in both approaches. In the case of freezing, the aim is to Pregnant C57BL/6J mice were anesthetized and emreduce damage to cells by the formation of extracellular bryonic day 14 (E14) fetuses were surgically extracted. ice crystals rather than intracellular ice. In contrast, vitri-
The hippocampi were dissected out and digested in fication aims to avoid ice crystal formation on both cool-0.25% trypsin-EDTA solution (Gibco, CA, USA) for 30 ing and warming by achieving glass-like solidification min with trituration every 15 min. [for review see (17) ]. Having established the first clini-Twice the volume of PBS was added to stop the dical application of vitrification in the cryopreservation of gestion and the tissues were sieved with a 70-µm cell oocytes for fertility treatment (15) , we showed that vitristrainer. The samples were centrifuged to pellet the cells fication protocols are preferable to slow-cooling freezand the cells were then plated with neurosphere medium. ing protocols for the preservation of oocytes and em-
The neurosphere medium consisted of DMEM/F12 bryos (17) . Slow-cooling freezing of human embryonic (Gibco) supplemented with N2 supplement (Gibco), 20 stem cell colonies in suspension is reportedly plagued ng/ml EGF (Gibco), and 10 ng/ml bFGF (Gibco). After by poor viability and abnormal differentiation upon re-2-3 weeks in culture visible neurospheres were present covery (12) . Most studies have concluded that slowand the culture was passaged. For passage, neurospheres cooling freezing protocols are suboptimal for cryopreswere allowed to settle in a microcentrifuge tube and then ervation of embryonic stem cells [for review see (7) ]. A mechanically dissociated using a 200-µl pipette before rapid cooling procedure for cryopreservation of hematoreplating in fresh neurosphere medium. All animal expoietic progenitor cells from human cord blood in soluperiments were approved by the Institutional Animal tions employing serum was described in an earlier report Care and Use Committee (IACUC) of the National Uni- (20) . There have been interesting reports on cryopreserversity of Singapore and were conducted in accordance vation of human and other primate embryonic stem cells with the Guide for the Care and Use of Laboratory Aniavoiding conventional slow-cooling method by directly mals, National Institutes of Health, USA. plunging into liquid nitrogen (5, 28, 29, 31, 39) . Although
Vitrification of Neurospheres these studies were a step forward, all of them employed serum or proteins of human or animal origin. Addition-
The protocol for vitrification of NSPCs is outlined in Figure 1 . All cryoprotectant solutions were prepared in ally, various concerns over the achievement of the glasslike vitreous state of samples need to be addressed. DMEM/F12. After three passages, neurospheres were either taken through vitrification and warming or kept We first sought to select the most promising concept to adopt as a basis for the development of protocols for as untreated controls. All experiments were performed at least in triplicate on batches of neurospheres isolated the cryopreservation of NSPCs. On explorative investigation of freezing strategies, we found that freezing of from tissue derived from different pregnant females. The procedure comprised a three-step exposure to cryopro-cells is detrimental to cell viability and the structural integrity of neurospheres compared to cooling in solu-tectants, where neurospheres were sequentially exposed to solutions containing increasing concentrations of cry-sucrose in DMEM/F12 and subsequently by 0.175 M on stepwise dilution with DMEM/F12. The durations of the oprotectans as detailed in Figure 1 . In each of the first two steps, the neurospheres were allowed to sink to the warming and dilution steps are schematically presented in Figure 1 . The whole dilution procedure took ϳ15 bottom of the microcentrifuge tube before the removal of the cryoprotectant solution and its subsequent substi-min. All treatments were performed at room temperature (23 ± 2°C). The neurospheres were then allowed to sink. tution with cryoprotectant of increased concentration. While exposed to the final vitrification solution (40% The excess solution was then removed and the neurospheres were washed in neurosphere culture medium v/v EG, 0.6 M sucrose, resulting in 65% w/v total solute concentration), neurospheres were packed in a "straw-before being placed in the incubator. After 30 min they were transferred to fresh culture media for routine cul-in-straw" configuration as previously described (18) . Briefly, neurospheres were aspirated into a 250-µl ster-ture until further analysis. ile, plastic straw. This 250-µl straw was then placed within a 500-µl straw. The 500-µl straw was then sealed Assay for Neural Stem Cell Markers with an impulse heat sealer. The entire procedure was
To determine whether the vitrification affected the performed at room temperature (23 ± 2°C), with a total neural stem or progenitor cell state, dissociated NSPCs duration of 9-10.5 min. Finally, the straws were imwere plated on poly-L-ornithine/fibronectin-coated slides mersed in liquid nitrogen. The durations of the various in a monolayer and maintained for 3 days in neurosphere steps in the procedure are schematically presented in medium. The progenitor or stem cells were then fixed Figure 1 .
by treatment with 4% paraformaldehyde for 20 min. Immunostaining was conducted sequentially using anti-
Warming of Neurospheres and Dilution
Sox2 (AB5603, Chemicon, Tenecula, CA, USA) and of Cryoprotectant anti-nestin (MAB353, Chemicon) antibodies for identification of neural stem or progenitor cell markers. Fluo-The straws containing neurospheres were warmed by immersion in a water bath at 38 ± 0.5°C for 30 s with rescence-conjugated Alexa Fluor secondary antibodies (Invitrogen, CA, USA) were used to visualize the pri-continuous shaking. Next the neurospheres were unpacked and expelled into 1 M sucrose in DMEM/F12 in mary antibodies and the coverslips were counterstained with DAPI in Prolong Antifade Gold mounting medium a 15-ml centrifuge tube. The sucrose concentration was reduced stepwise first to 0.7 M by dilution with 0.25 M (Invitrogen). The immunostained cells were then imaged by sequential scanning with a confocal microscope an investigator blind to the treatment and expressed as a percentage of the total cell count. (LSM 510, Carl Zeiss Microimaging GmbH, Germany).
Statistical Analysis Cell Proliferation Assay
Values obtained for vitrified samples were compared In order to assay the rate of cell proliferation of the to those of the controls by Student's t-test (SPSS version NSPCs, the control neurospheres were washed thor-12, SPSS Inc., Chicago, IL, USA). A value of p < 0.05 oughly using culture medium, prior to dissociation and was considered statistically significant. All data are restaining, mimicking the dilution process of the vitrified ported as mean ± SEM. group for procedure consistency. The neurospheres were dissociated using 0.25% trypsin-EDTA solution and the RESULTS cells were replated on poly-L-ornithine/laminin-coated Effects of Vitrification on Expression of Stem coverslips. The cells were allowed to adhere to the or Progenitor Cell Markers coverslips and 5-bromo-2′-deoxyuridine (BrdU; Sigma-Aldrich, MO, USA) was then added to the culture me-To investigate whether the process of vitrification dium to a final concentration of 10 µM and incubated had an effect on the stem or progenitor cell state of with the dissociated NSPCs for 24 h. The cells were NSPCs, expression of the neural stem or progenitor cell then fixed with 4% paraformaldehyde for 20 min. Immarkers, nestin and Sox2, was assayed. The cells were munostaining was conducted to detect the BrdU incorplated on poly-L-ornithine and fibronectin-coated coverporation using an anti-BrdU antibody (1:100, BRD.3, slips and allow to attached and recover for 3 days. The Neomarkers, Lab Vision Corporation, CA, USA) and
vitrified NSPCs were found to express nestin and Sox2 detected using Alexa Fluor 555 conjugate secondary an- (Fig. 2) . To investigate whether the NSPCs would lose tibody (Invitrogen). The cells were counterstained with their stem/progenitor cell state upon further passaging, DAPI to reveal all nuclei. The cells were imaged by the neurosphere cultures were passaged three times and sequential scanning with a confocal microcope (Fluothe assay was conducted again. After three passages, the view 1000, Olympus, Japan). An investigator blind to NSPCs were still found to express nestin and Sox2. This the treatment conditions counted the number of BrdUindicates that the neural stem or progenitor cell state was immunoreactive cells and DAPI-positive nuclei and the maintained for at least three passages after vitrification number of BrdU-positive cells was expressed as a per- (Fig. 2B ). centage of the total cell count.
Effect of Vitrification on the Rate of Proliferation Assay for Multipotent Differentiation
The proliferation rate of the vitrified NSPCs was To assay for multipotent differentiation into neurons, compared with the untreated group by a BrdU incorporaastrocytes, and oligodendrocytes, dissociated NSPCs tion assay. The proliferation rate over 24 h was calcuwere plated on poly-L-ornithine/laminin-coated coverlated as the percentage of BrdU-immunoreactive cells in slips. Differentiation was induced with 0.5% fetal calf the total DAPI-stained cell count. Vitrification did not serum (Hyclone Laboratories Inc., UT, USA) in neusignificantly alter the number of cells labeled with BrdU rosphere medium without EGF and bFGF. After 1 day, compared to the untreated control ( Fig. 3B compared the medium was replaced with DMEM/F12 with N2 with Fig. 3A) . Quantification of the BrdU-positive cells supplement and the cells were allowed to differentiate did not reveal any significant change in the rate of profor a further 6 days. The differentiated cells were then liferation in vitrified NSPCs compared to the untreated fixed by treatment with 4% paraformaldehyde for 20 control (Fig. 3C ). min. Immunostaining was conducted sequentially using Multipotent Differentiation After Vitrification an anti-MAP2a+b antibody (MAB378, Chemicon) for identification of neurons, an anti-glial fibrillary acidic
The neurons, astrocytes, and oligodendrocytes were identified by immunostaining with cell type-specific protein (GFAP) antibody (Z0334, Dako, Denmark) for identification of astrocytes and an anti-CNPase antibody markers ( Fig. 4) . Both untreated and vitrified NSPCs differentiated into cells expressing either GFAP or (MAB326R, Chemicon) for identification of oligodendrocytes. Fluorescence-conjugated Alexa Fluor second-MAP2a+b ( Fig. 4A and B , respectively) and GFAP or CNPase ( Fig. 4C and D, respectively) . The number of ary antibodies (Invitrogen) were used to visualize the primary antibodies and the coverslips were counter-each of the three cell types was quantified as a percentage of the total cell number counted by DAPI counter-stained with DAPI. The differentiated cells were then imaged by sequential scanning with a confocal micro-staining. Both untreated and vitrified NSPCs were able to differentiate into 7-11% neurons, 80-86% astrocytes, scope (Fluoview 1000, Olympus). The numbers of neurones, oligodendrocytes and astrocytes were counted by and <1% oligodendrocytes (Fig. 4E ). There were no sig- nificant differences in the differentiation in untreated of NSPCs following recovery from vitrification, which had been mentioned as a problem following cryopreser-and vitrified cells.
vation of embryonic stem cells in a protocol involving DISCUSSION the use of dimethylsulfoxide (DMSO) (12) . This problem could be attributed to the role of DMSO in promot-The present study aimed to investigate whether cryopreservation of stem cells without the use of proteins ing differentiation, mechanical and osmotic stresses, and other chemical and physical factors (2, 9) . Maintenance and serum was feasible. Specifically, we have established a vitrification protocol without any protein or se-of progenitor or stem cell properties following vitrification is likely to be important in clinical application as rum additives for the sterile cryopreservation of functional NSPCs. It is essential that NSPCs maintain their expansion of the NSPCs will probably be required to reach the desired cell number for cell replacement multipotency after cryopreservation for the benefit of basic research and for future clinical application. There-therapy. Careful selection of the constituents of the cryopres-fore, after the vitrification-warming cycle, neurospheres were assayed for their ability to differentiate into neu-ervation solutions is important to avoid toxic effects. To ensure low toxicity, we carefully assessed a number of rons, astrocytes, and oligodendrocytes. All three neural cell types were found in differentiated NSPCs after vitri-vitrification solutions and conditions for vitrification (22) . The vitrification solution evaluated here used EG fication-warming cycle. There was no significant difference in the proportion of the three cell types between and sucrose as cryoprotectants. EG is regarded as a promising cryoprotectant due to its high permeability the untreated and vitrified NSPCs. Thus, these results indicate that the vitrification process does not affect the and relatively low molecular weight (62 Da) (35) . Sucrose is an easily soluble, cheap cryoprotectant additive multipotent differentiation of NSPCs Expression of nestin and Sox2, two commonly used with little or no toxicity and, in contrast to EG, is a nonpenetrating cryoprotectant. Our previous experience neural stem or progenitor cell markers, was studied to ensure that the state of the NSPCs was not affected by in cryopreservation by vitrification had shown that the use of mixtures of penetrating and nonpenetrating cryo-vitrification. Both the markers were detected in NSPCs recovered from vitrification and also three passages after protectants in certain proportions is a feasible approach for cryopreservation of human oocytes (17) , encapsu-recovery from vitrification. This shows that the vitrification procedures did not alter the expression of these im-lated hepatocytes (19, 38) , and self-assembled aggregates (22) . Therefore, we employed this methodology in vitri-portant stem cell markers. In our study, there was no evidence for stimulation of spontaneous differentiation fying NSPCs. In our protocol, the cells were only ex- posed briefly to the penetrating cryoprotectant; after that serum and proteins can be effective when vitrification is employed. Therefore, we propose vitrification as a pre-the EG was removed completely through the dilution process. Hence, we believe that the use of EG as one of ferred method for cryopreservation of NSPCs. A major drawback of existing cryopreservation proto-the cryoprotectants in our vitrification protocol did not cause toxic effects in the model we used. This cryopres-cols has been that it is difficult to ensure sterility. Not only can pathogens survive cryopreservation but, as ex-ervation protocol was cautiously designed so that no penetrating cryoprotectant will remain in cells or will be perience in the field of assisted reproduction has shown, cross-contamination can even occur during cryostorage transferred into patient or culture medium with cells. The vitrification solution evaluated in the current study (25, 30, 34) . We have invented a "straw-in-straw" method using readily available 250-and 500-µl straws, which was invented by us and lead to the first live human birth following vitrification of human oocytes (15) . In this re-we arranged into a "straw-in-straw" configuration (18) , as a simple and cost-effective strategy to prevent con-gards, it can be consider likely to be safe for the prospect of cryopreservation of human stem cells for clinical tamination. This approach means that samples can be cooled and warmed by direct immersion in liquid nitro-applications. We had found that vitrification, even without any components of human or animal origin, allows gen and a water bath, respectively. Previously, we have pioneered the "straw-in-straw" technique in the cryo-preservation of neurospheres with high cell viability. In contrast, freezing, even incorporating fetal calf serum, preservation of embryos (15, 16, 18) , cell-matrix systems (19, 38) , and hepatocyte spheroids (22) . Together with led to significant lost of viability (32) . A comprehensive study on the long-term impact of "freezing" on NSPCs our previous work, the present data suggest that this strategy can be incorporated in an effective cryopreser-also showed a decline in cell viability (26) .
Recent studies that moved away from the slow-cool-vation protocol for NSPCs.
Here we have discussed a cost-efficient and simple ing "freezing" concept for the cryopreservation of embryonic stem cells showed no evidence of altered pluri-protocol for the cryopreservation of neurospheres by vitrification. While it is uncertain whether neurospheres potency or karyotype abnormalities (28, 29, 31, 39) . We have also conducted studies to investigate the effects of will be the preferred culture system for potential future clinical application of NSPCs (11) , the ability to pre-vitrification on the chromosomal status of human oocytes (15) and mammalian neurospheres (32) and did not find serve the unsupported three-dimensional structure of neurospheres by vitrification suggests that this approach evidence of chromosomal abnormality following vitrification.
could be considered as a method to the preservation of NSPCs in three-dimensional microfabricated structures Currently, NSPCs are typically cryopreserved by freezing. Freezing is usually achieved by either rapid or scaffolds (e.g., nerve conduits for spinal cord repair) (33) . Importantly, we have shown in the present report freezing or slow-cooling protocols. Protocols that involve freezing, which inevitably results in the formation that this protocol did not affect the proliferation or differentiation of NSPCs. With the complete avoidance of of ice crystals, may damage sensitive cells. Moreover, slow cooling has also been shown to have persistent ad-products of human or animal origin, we hope that this protocol can serve as starting point for development of verse effects on embryonic stem cells (14). DMSO with or without fetal calf serum has been commonly used as a protein-and serum-free vitrification protocols for the cryopreservation of human stem cells, especially human cryoprotectant (3, 6, 26) . Although not evident in a recent study by Milosevic and colleagues (26) , the use of neural stem cells that may eventually be used in clinical settings. DMSO as a cryoprotectant can have adverse effects on differentiation (10 also important that they should be free from foreign proteins and sera so as to avoid any possible risk of contam-REFERENCES ination (23) . Xeno-free cryopreservation protocols have sometimes replaced animal proteins with human pro- that we have shown that cell cryopreservation without
